Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,501.47
+2.560.10%
Number of Gainers:57
Number of Losers:39
Number of Flat:1
PE:- -
High:2,506.76
Open:2,498.91
Low:2,496.42
Close:2,498.90
Volume:400.83M
Turnover:81.76B
Market Cap:52.39T
Float Cap:49.01T

Loading ...

Premarket: Nasdaq Futures Slip 0.1% as Traders Keep Close Watch on Treasury Yields and Oil Prices

Deep News
·
Oct 05

BNP Paribas Adjusts Price Target on Intel to $125 From $75, Maintains Neutral Rating

MT Newswires Live
·
Oct 05

Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
Oct 05

Alpha Modus Wins US Court Denial of Motion to Dismiss in Patent Infringement Case

Reuters
·
Oct 05

US Stocks-Wall St Set for Muted Open as Tech Stocks Take a Breather

Reuters
·
Oct 05

Immunome Issues 4,425,487 Shares to Bristol-Myers Squibb in Unregistered Sale

Reuters
·
Oct 05

Top 20 Vehicles Sold in US in Third Quarter of 2026

Reuters
·
Oct 05

Accenture Creates Advanced Intelligence Group to Tackle Complex AI Projects

Reuters
·
Oct 05

Zscaler Collaborates with IBM, Red Hat to Shield Private Apps During Patch Gaps

Reuters
·
Oct 05

What's Next for Tesla Stock After Strong Q3 Deliveries

Dow Jones
·
Oct 05

Visa finds 46% in Asia Pacific may use stablecoins by 2031

cryptonews
·
Oct 05

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

THOMSON REUTERS
·
Oct 05

Zscaler Collaborates with Ibm and Red Hat to Protect Private Applications from Frontier AI-Powered Threats

THOMSON REUTERS
·
Oct 05

Tesla Stock Forecast: Q3 Delivery Beat Shifts Focus to Margins and AI

TradingKey
·
Oct 05

Bristol-Myers Squibb Company : Leerink Partners Cuts to Market Perform from Outperform; Cuts Target Price to $59 from $73

THOMSON REUTERS
·
Oct 05

Microsoft Stock: Melius Upgrades MSFT to Buy, Raises Target to $665 as AI Fears Boost Security Demand

TIPRANKS
·
Oct 05

Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Genmab (GMAB)

TIPRANKS
·
Oct 05

Eli Lilly Presents New Ebglyss Data from Phase 3 ADorable-1 Pediatric Atopic Dermatitis Study at Fall Clinical 2026

Reuters
·
Oct 05

Google's Deals With Polish Media Outlets Under Regulator Scrutiny

MT Newswires Live
·
Oct 05

Align Slips as Brokerage Downgrades Rating to 'in Line' over Slowing Demand

Reuters
·
Oct 05